ENPP2 and fatty liver disease: Furthermore, preclinical evidence indicates that IL-6/GP130/JAK/STAT3 pathway activation upregulates autotaxin expression in adipocytes, while genetic suppression of autotaxin enhances insulin sensitivity and reduces hepatic steatosis in knockout mice compared to wild-type controls [19].